Walleye Trading LLC Adverum Biotechnologies, Inc. Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $113,798 - $196,959	-54,711 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $183,828 - $577,748	54,711 New	54,711 $191,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $236,937 - $343,366	-24,079 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $234,984 - $493,694	22,814 Added 1803.48%	24,079 $248,000
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $10,094 - $20,644	1,265 New	1,265 $12,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.